Rate of COVID-19 Delta acceleration appears to slow in Luhansk PR thanks to Sputnik Light Vaccine campaign
In July, the government of the People’s Republic of Luhansk launched a massive vaccine project to counter a worrying rise in COVID-19 cases caused by the wild delta variant which had reached the Donbas region hitting both Luhansk and Donetsky republics as well as the neighbouring Russian Federation, particularly Moscow.
The Sputnik Light (Gam-COVID-Vac) ‘rescue’ was helped by the generosity of Russian humanitarianism but according to Luhansk officials it was more importantly the vaccine of choice, regardless, because of modeling which strongly indicated the Light version of Sputnik V was a single shot, emergency outbreak response option.
by Micheal John and Sharon Santiago
“Maybe not intended,” says Dr. Fred Harris, a biostatistician and infectious disease researcher in Singapore, “but Luhansk has become a test sphere for the modelled fast response vaccine concept and it seems to be proving the worth of this highly efficacious vectored-virus technology solution that uses a fast-response single shot of the Sputnik V.”
Trust in the Sputnik series of vaccines is so high in fact that the “Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the Serum Institute of India (SII) have announced plans to start the production of the Sputnik V vaccine in India,” according to India Today.
“The first batch of Sputnik V vaccine is expected to be produced at the Serum Institute’s facilities [in India] starting September,” say officials of both institutes in a release.
“The Sputnik fast response vaccine has humanitarians paying close attention. Africa and Asia are suffering under COVID-19 and any rapid vaccination programme would be a blessing,” says expert.
Luhansk PR and regional data for January 18, 2022
In addition to some 70 other nations which are publicly set out as users of the Sputnik V vaccine through various channels including donations, Abkhazia, Donetsk, Luhansk, South Ossetia, and Transnistria according to both official and unofficial sources to CSPaC are receiving as donations from Russia, and using, the Sputnik V vaccine made by the Gamaleya Research Institute of Epidemiology and Microbiology. North Ossetia-Alania, a former autonamous region of the Russian Federation, is tracked because of its relationship and population intermingling with South Ossetia and Georgia.
Dr. Harris continued in a Zoom interview to explain that there is some enthusiasm for this experiment.
“Obviously, infectious disease researchers are extremely interested in what is happening in Luhansk PR. Statistically, enough data has been collected to imply that the trend is going in the right direction but more vaccinations are needed and people in the regions must be encouraged to get vaccinated at the earliest possible opportunity and to always wear a mask and continue to wash hands vigorously. The Luhansk PR is offering a hotline phone number that civilians can use anonymously to obtain information or to inquire about vaccines or symptoms.”
According to health officials in Luhansk,“On July 31, a campaign to vaccinate the population with the drug “Sputnik Light” was launched in Pervomaisk. Vaccination took place in the Pervomaiskaya city multidisciplinary hospital. Doctors strongly recommend getting vaccinated against the coronavirus at the first opportunity.”
“Sputnik Light” is a lighter analogue of the Russian vaccine “Sputnik V”, which does not require the introduction of the second component of the drug. Sputnik Light was also developed by the Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation named after N. F. Gamaleya. The vaccine was registered on March 29, 2021 after the end of the regulated procedure for certification of the medication, explained Luhansk officials.